A citation-based method for searching scientific literature

Tanja Grimmig, Eva-Maria Moll, Kerstin Kloos, Rebecca Thumm, Romana Moench, Simone Callies, Jennifer Kreckel, Malte Vetterlein, Joerg Pelz, Buelent Polat, Sudipta Tripathi, Roberta Rehder, Carmen M Ribas, Anil Chandraker, Christoph-T Germer, Ana Maria Waaga-Gasser, Martin Gasser. Cancer Growth Metastasis 2017
Times Cited: 9







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer.
Adham S Bear, Laura C Kennedy, Joseph K Young, Serena K Perna, Joao Paulo Mattos Almeida, Adam Y Lin, Phillip C Eckels, Rebekah A Drezek, Aaron E Foster. PLoS One 2013
79
33

Biochemical studies of the thermal effects on DNA modifications by the antitumor cisplatin and their repair.
Anna Halamikova, Oldrich Vrana, Jana Kasparkova, Viktor Brabec. Chembiochem 2007
12
22

Exposure-response relationships for oxaliplatin-treated colon cancer cells.
Mark N Kirstein, Stephanie A Root, Megan M Moore, Katie M Wieman, Brent W Williams, Pamala A Jacobson, Paul H Marker, Todd M Tuttle. Anticancer Drugs 2008
13
22

Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis.
Vahan Kepenekian, Marie-Thérèse Aloy, Nicolas Magné, Guillaume Passot, Emma Armandy, Evelyne Decullier, Annie Sayag-Beaujard, François-Noël Gilly, Olivier Glehen, Claire Rodriguez-Lafrasse. Cell Stress Chaperones 2013
7
28

Local tumour hyperthermia as immunotherapy for metastatic cancer.
Seiko Toraya-Brown, Steven Fiering. Int J Hyperthermia 2014
139
22

Prevention of scald injury on the peritoneo-serosal surface in advanced gastric cancer patients treated with intraperitoneal hyperthermic perfusion.
S Fujimoto, M Kokubun, R D Shrestha, K Kobayashi, S Kiuchi, C Konno, M Takahashi, K Okui. Int J Hyperthermia 1991
14
22

Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
D Atallah, V Marsaud, C Radanyi, M Kornprobst, R Rouzier, D Elias, J-M Renoir. Int J Hyperthermia 2004
30
22

The cellular and molecular basis of hyperthermia.
Bert Hildebrandt, Peter Wust, Olaf Ahlers, Annette Dieing, Geetha Sreenivasa, Thoralf Kerner, Roland Felix, Hanno Riess. Crit Rev Oncol Hematol 2002
792
22

In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia.
Kai-Lin Yang, Cheng-Chung Huang, Mau-Shin Chi, Hsin-Chien Chiang, Yu-Shan Wang, Chien-Chung Hsia, Gabor Andocs, Hsin-Ell Wang, Kwan-Hwa Chi. Oncotarget 2016
30
22

Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
Omeed Moaven, Konstantinos I Votanopoulos, Perry Shen, Paul Mansfield, David L Bartlett, Greg Russell, Richard McQuellon, John H Stewart, Edward A Levine. Ann Surg Oncol 2020
8
25

A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors.
Edward A Levine, Konstantinos I Votanopoulos, Perry Shen, Greg Russell, Joyce Fenstermaker, Paul Mansfield, David Bartlett, John H Stewart. J Am Coll Surg 2018
35
22

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Karolina Sikorska, Jules H Schagen van Leeuwen, Henk W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Jacobus van der Velden, Henriëtte J Arts, Leon F A G Massuger,[...]. N Engl J Med 2018
472
22

How do cells respond to their thermal environment?
James R Lepock. Int J Hyperthermia 2005
90
22

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
R L Dedrick, C E Myers, P M Bungay, V T DeVita. Cancer Treat Rep 1978
665
22


Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.
R Wadhwa, T Sugihara, A Yoshida, H Nomura, R R Reddel, R Simpson, H Maruta, S C Kaul. Cancer Res 2000
163
11

The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.
Mariangela De Robertis, Emanuela Massi, Maria Luana Poeta, Simone Carotti, Sergio Morini, Loredana Cecchetelli, Emanuela Signori, Vito Michele Fazio. J Carcinog 2011
302
11

Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.
W-J Lu, N P Lee, S C Kaul, F Lan, R T P Poon, R Wadhwa, J M Luk. Cell Death Differ 2011
103
11

A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.
Pui-Kei Wu, Seung-Keun Hong, Sudhakar Veeranki, Mansi Karkhanis, Dmytro Starenki, Jose A Plaza, Jong-In Park. Mol Cell Biol 2013
42
11

Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer.
Perri Rozenberg, Judit Kocsis, Moran Saar, Zoltán Prohászka, George Füst, Zvi Fishelson. Int J Cancer 2013
35
11


Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.
Xiao-Xin Sun, Kishore B Challagundla, Mu-Shui Dai. EMBO J 2012
114
11

Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1.
L F Burbulla, J C Fitzgerald, K Stegen, J Westermeier, A-K Thost, H Kato, D Mokranjac, J Sauerwald, L M Martins, D Woitalla,[...]. Cell Death Dis 2014
61
11

Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
David Pilzer, Moran Saar, Keizo Koya, Zvi Fishelson. Int J Cancer 2010
33
11

Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells.
Kimberley A Beaumont, David S Hill, Sheena M Daignault, Goldie Y L Lui, Danae M Sharp, Brian Gabrielli, Wolfgang Weninger, Nikolas K Haass. J Invest Dermatol 2016
29
11


Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging.
Shinji Miwa, Shuya Yano, Hiroaki Kimura, Mako Yamamoto, Makoto Toneri, Yasunori Matsumoto, Fuminari Uehara, Yukihiko Hiroshima, Takashi Murakami, Katsuhiro Hayashi,[...]. Cell Cycle 2015
19
11

Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
Ji Young Yoo, Jihoon Ryu, Ran Gao, Tomoko Yaguchi, Sunil C Kaul, Renu Wadhwa, Chae-Ok Yun. J Gene Med 2010
27
11

On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.
Custer C Deocaris, Sunil C Kaul, Renu Wadhwa. Cell Stress Chaperones 2006
126
11

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
Paula M De Angelis, Debbie H Svendsrud, Katherine L Kravik, Trond Stokke. Mol Cancer 2006
130
11


A bipartite interaction between Hsp70 and CHIP regulates ubiquitination of chaperoned client proteins.
Huaqun Zhang, Joseph Amick, Ritu Chakravarti, Stephanie Santarriaga, Simon Schlanger, Cameron McGlone, Michelle Dare, Jay C Nix, K Matthew Scaglione, Dennis J Stuehr,[...]. Structure 2015
46
11

CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control.
Jin-Na Min, Ryan A Whaley, Norman E Sharpless, Pamela Lockyer, Andrea L Portbury, Cam Patterson. Mol Cell Biol 2008
168
11

Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha.
Weibo Luo, Jun Zhong, Ryan Chang, Hongxia Hu, Akhilesh Pandey, Gregg L Semenza. J Biol Chem 2010
155
11


Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity.
Khosrow Rezvani, Yanfen Teng, David Shim, Mariella De Biasi. J Neurosci 2007
90
11


CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
Shouyu Wang, Xuming Wu, Jianbing Zhang, Yansu Chen, Jin Xu, Xiaowei Xia, Song He, Fulin Qiang, Aiping Li, Yongqian Shu,[...]. Gut 2013
87
11

Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
Xuelian Cui, Zhenling Li, Junjie Piao, Jinzi Li, Longshan Li, Zhenhua Lin, Aihua Jin. Hum Pathol 2017
12
11

Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Aurore Saudemont, Abdelbasset Hamrouni, Philippe Marchetti, Jizhong Liu, Nathalie Jouy, Dominique Hetuin, Francesco Colucci, Bruno Quesnel. Cancer Res 2007
28
11



Identification and functional characterization of nuclear mortalin in human carcinogenesis.
Jihoon Ryu, Zeenia Kaul, A-Rum Yoon, Ye Liu, Tomoko Yaguchi, Youjin Na, Hyo Min Ahn, Ran Gao, Il-Kyu Choi, Chae-Ok Yun,[...]. J Biol Chem 2014
35
11

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.
Hemant K Roy, Bola F Olusola, Dahn L Clemens, William J Karolski, Anne Ratashak, Henry T Lynch, Thomas C Smyrk. Carcinogenesis 2002
263
11


CHIP activates HSF1 and confers protection against apoptosis and cellular stress.
Qian Dai, Chunlian Zhang, Yaxu Wu, Holly McDonough, Ryan A Whaley, Virginia Godfrey, Hui-Hua Li, Nageswara Madamanchi, Wanping Xu, Len Neckers,[...]. EMBO J 2003
241
11

Mitochondrial Hsp70/MIM44 complex facilitates protein import.
H C Schneider, J Berthold, M F Bauer, K Dietmeier, B Guiard, M Brunner, W Neupert. Nature 1994
317
11

Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells.
Mai Tsuchiya, Yuka Nakajima, Naoya Hirata, Tamaki Morishita, Hiroyuki Kishimoto, Yasunari Kanda, Keiji Kimura. Biochem Biophys Res Commun 2014
10
11

Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer.
Karan Bhuripanyo, Yiyang Wang, Xianpeng Liu, Li Zhou, Ruochuan Liu, Duc Duong, Bo Zhao, Yingtao Bi, Han Zhou, Geng Chen,[...]. Sci Adv 2018
14
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.